169 related articles for article (PubMed ID: 31865910)
1. VIO: ontology classification and study of vaccine responses given various experimental and analytical conditions.
Ong E; Sun P; Berke K; Zheng J; Wu G; He Y
BMC Bioinformatics; 2019 Dec; 20(Suppl 21):704. PubMed ID: 31865910
[TBL] [Abstract][Full Text] [Related]
2. The Ontology of Biological and Clinical Statistics (OBCS)-based statistical method standardization and meta-analysis of host responses to yellow fever vaccines.
Zheng J; Li H; Liu Q; He Y
Quant Biol; 2017 Dec; 5(4):291-301. PubMed ID: 30034908
[TBL] [Abstract][Full Text] [Related]
3. Empowering standardization of cancer vaccines through ontology: enhanced modeling and data analysis.
Zheng J; Li X; Masci AM; Kahn H; Huffman A; Asfaw E; Pan Y; Guo J; He V; Song J; Seleznev AI; Lin AY; He Y
J Biomed Semantics; 2024 Jun; 15(1):12. PubMed ID: 38890666
[TBL] [Abstract][Full Text] [Related]
4. Ontology-Based Vaccine Adverse Event Representation and Analysis.
Xie J; He Y
Adv Exp Med Biol; 2017; 1028():89-103. PubMed ID: 29058218
[TBL] [Abstract][Full Text] [Related]
5. Ontology-based Precision Vaccinology for Deep Mechanism Understanding and Precision Vaccine Development.
Xie J; Zi W; Li Z; He Y
Curr Pharm Des; 2021; 27(7):900-910. PubMed ID: 33238868
[TBL] [Abstract][Full Text] [Related]
6. Yellow fever 17D vaccine safety and immunogenicity in the elderly.
Monath TP; Cetron MS; McCarthy K; Nichols R; Archambault WT; Weld L; Bedford P
Hum Vaccin; 2005; 1(5):207-14. PubMed ID: 17012867
[TBL] [Abstract][Full Text] [Related]
7. The Ontology of Biological and Clinical Statistics (OBCS) for standardized and reproducible statistical analysis.
Zheng J; Harris MR; Masci AM; Lin Y; Hero A; Smith B; He Y
J Biomed Semantics; 2016 Sep; 7(1):53. PubMed ID: 27627881
[TBL] [Abstract][Full Text] [Related]
8. Gene Ontology analysis in multiple gene clusters under multiple hypothesis testing framework.
Zhong S; Xie D
Artif Intell Med; 2007 Oct; 41(2):105-15. PubMed ID: 17913480
[TBL] [Abstract][Full Text] [Related]
9. 17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005.
Barrett AD; Monath TP; Barban V; Niedrig M; Teuwen DE
Vaccine; 2007 Apr; 25(15):2758-65. PubMed ID: 17368349
[TBL] [Abstract][Full Text] [Related]
10. The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines.
Marcos E; Zhao B; He Y
J Biomed Semantics; 2013 Nov; 4(1):40. PubMed ID: 24279920
[TBL] [Abstract][Full Text] [Related]
11. Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.
Monath TP; Seligman SJ; Robertson JS; Guy B; Hayes EB; Condit RC; Excler JL; Mac LM; Carbery B; Chen RT;
Vaccine; 2015 Jan; 33(1):62-72. PubMed ID: 25446819
[TBL] [Abstract][Full Text] [Related]
12. Ontology-supported research on vaccine efficacy, safety and integrative biological networks.
He Y
Expert Rev Vaccines; 2014 Jul; 13(7):825-41. PubMed ID: 24909153
[TBL] [Abstract][Full Text] [Related]
13. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
[TBL] [Abstract][Full Text] [Related]
14. [Construction of recombinant yellow fever virus 17D containing 2A fragment as a vaccine vector].
Xiaowu P; Fu WC; Guo YH; Zhang LS; Xie TP; Xinbin G
Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):492-8. PubMed ID: 16755933
[TBL] [Abstract][Full Text] [Related]
15. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity.
Querec T; Bennouna S; Alkan S; Laouar Y; Gorden K; Flavell R; Akira S; Ahmed R; Pulendran B
J Exp Med; 2006 Feb; 203(2):413-24. PubMed ID: 16461338
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing.
Pugachev KV; Ocran SW; Guirakhoo F; Furby D; Monath TP
Vaccine; 2002 Jan; 20(7-8):996-9. PubMed ID: 11803058
[TBL] [Abstract][Full Text] [Related]
17. VIGET: A web portal for study of vaccine-induced host responses based on Reactome pathways and ImmPort data.
Brunson T; Sanati N; Huffman A; Masci AM; Zheng J; Cooke MF; Conley P; He Y; Wu G
Front Immunol; 2023; 14():1141030. PubMed ID: 37180100
[TBL] [Abstract][Full Text] [Related]
18. Development and application of an interaction network ontology for literature mining of vaccine-associated gene-gene interactions.
Hur J; Özgür A; Xiang Z; He Y
J Biomed Semantics; 2015; 6():2. PubMed ID: 25785184
[TBL] [Abstract][Full Text] [Related]
19. The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.
Ferreira CC; Campi-Azevedo AC; Peruhype-Magalhāes V; Costa-Pereira C; Albuquerque CP; Muniz LF; Yokoy de Souza T; Oliveira ACV; Martins-Filho OA; da Mota LMH
Expert Rev Vaccines; 2018 Jan; 17(1):79-90. PubMed ID: 29172832
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.
Bassi MR; Larsen MA; Kongsgaard M; Rasmussen M; Buus S; Stryhn A; Thomsen AR; Christensen JP
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004464. PubMed ID: 26886513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
